CHIN-FENG TSAIKUEI-CHUAN CHAN2026-10-162026-10-162003-12-01Pure ID: 15333970Pure UUID: 7f0a8cb5-558a-41f3-8d8f-ec71a444649d10.1016/j.ehj.2003.08.014https://www.scopus.com/pages/publications/10744221998https://scholars.csmu.edu.tw/handle/123456789/23420Aims: This study aimed to assess whether enalapril could improve cardioversion outcome and facilitate sinus rhythm maintenance after conversion of chronic atrial fibrillation (AF). Methods and results: Patients with chronic AF for more than 3 months were assigned to receive either amiodarone (200 mg orally 3 times a day; group I: n=75) or the same dosage of amiodarone plus enalapril (10 mg twice a day; group II: n=70) 4 weeks before scheduled external cardioversion. The end-point was the time to first recurrence of AF. In 125 patients (86.2%), AF was converted to sinus rhythm. Group II had a trend to a trend to a lower rate of immediate recurrence of AF than group I did (4.3% vs 14.7%, P=0.067). Kaplan-Meier analysis demonstrated a higher probability of group II remaining in sinus rhythm at 4 weeks (84.3% vs 61.3%, P=0.002) and at the median follow-up period of 270 days (74.3% vs 57.3%, P=0.021) than in group II. Conclusion: The addition of enalapril to amiodarone decreased the rate of immediate and subacute arrhythmia recurrences and facilitated subsequent long-term maintenance of sinus rhythm after cardioversion of persistent AF.9enUse of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillationResults of a prospective and controlled studyjournal article